Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported CORT revenue for 2025-12-31 was $761.4M. Net income was $99.7M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Use this CORT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CORT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CORT SEC filings page. Lician reads the product cache first so this HTML stays unique to Corcept Therapeutics Incorporated even when a live quote feed is slow.
Latest cached year on this hub. Full CORT income, balance, and cash tables.